44 results
8-K
EX-10.4
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
to such Secondary Securities, the sum of (I) the Black Scholes Consideration Value of each such Option, if any, (II) the fair market value (as reasonably … determined jointly by the Holder and the Company in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right
8-K
EX-4.1
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
transaction solely with respect to such Primary Security, minus (y) with respect to such Secondary Securities, the sum of (I) the Black Scholes Consideration … ) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right, if any, and (III) the fair market value (as reasonably determined jointly
8-K
EX-4.3
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) the Black Scholes Consideration Value of each such Option, if any, (II) the fair market value (as reasonably determined jointly by the Holder … and the Company in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right, if any, and (III) the fair market value
8-K
EX-4.2
ehxyae47
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.6
hpfbl y67x04kx
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.1
2tpwlvu l3keg
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-4.1
yk7qyn vpx
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
lr3hr6fdu3
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.2
572n3vpmotnynqali4
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.1
st893ue2d7cidb26e7
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-4.2
hrj01
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K/A
EX-99.3
oz1t1kke71c8guahsa
19 Oct 23
Financial Statements and Exhibits
5:23pm
8-K
EX-99.3
xh5br7m0
5 Oct 23
Index to Financial Statements
5:12pm